Literature DB >> 18234168

Two models of homocysteine behavior in acute myocardial infarction.

Alvaro Osorio1, Esperanza Ortega, Estrella Ruiz-Requena.   

Abstract

OBJECTIVES: To study homocysteine (Hcy) levels during post-infarction follow-up. METHODS AND
RESULTS: In this study, serum Hcy levels were measured in 90 healthy individuals and in 127 patients with acute myocardial infarction (MI) on the day of infarction (day 0) and days 2, 5, 7, 9, and 11 post-infarction, comparing Hcy levels in MI patients on day 0 with their follow-up results and with levels in controls. Overall, MI patients had higher Hcy levels on day 0 versus controls. However, the behavior of Hcy levels differed between two groups of MI patients. Thus, patients with similar Hcy levels to controls on day 0 showed significantly higher levels on days 2, 5, 7, 9, and 11 post-infarction than on day 0. In contrast, patients with significant higher Hcy levels than controls on day 0 showed significantly lower levels on days 2, 5, 7, 9, and 11 post-infarction than on day 0.
CONCLUSIONS: Different behaviors of Hcy levels in MI patients might correspond to a history or absence of history of asymptomatic myocardial ischemia. Further research is required to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18234168     DOI: 10.1016/j.clinbiochem.2007.05.014

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.

Authors:  A Osorio; E Ortega; T de Haro; J M Torres; P Sánchez; E Ruiz-Requena
Journal:  Mol Cell Biochem       Date:  2011-03-09       Impact factor: 3.396

2.  Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period.

Authors:  Amina Valjevac; Alen Dzubur; Emina Nakas-Ićindić; Almira Hadzović-Dzuvo; Asija Zaćiragić; Orhan Lepara; Amila Arslanagić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.